Nonmelanoma Skin Cancer of the Head and Neck: Nonsurgical Treatment
dc.contributor.author | Ermertcan A.T. | |
dc.contributor.author | Hellings P.W. | |
dc.contributor.author | Cingi C. | |
dc.date.accessioned | 2024-07-22T08:19:22Z | |
dc.date.available | 2024-07-22T08:19:22Z | |
dc.date.issued | 2012 | |
dc.description.abstract | Nonmelanoma skin cancer (NMSC) is one of the most prevalent types of cancer worldwide, with basal cell carcinoma and squamous cell carcinoma being the most frequent histologic types. Surgical excision remains the mainstay of treatment, but nonsurgical treatment options may be indicated in specific cases. Nonsurgical treatment options for NMSC may be preferred as good alternatives under certain circumstances. This review provides a comprehensive overview of the nonsurgical treatment modalities for NMSCs, such as curettage and electrodesiccation, cryotherapy, radiotherapy, laser, photodynamic therapy, immunotherapy, and retinoid therapy. © 2012 Elsevier Inc. | |
dc.identifier.DOI-ID | 10.1016/j.fsc.2012.08.004 | |
dc.identifier.issn | 15581926 | |
dc.identifier.uri | http://akademikarsiv.cbu.edu.tr:4000/handle/123456789/17657 | |
dc.language.iso | English | |
dc.subject | Age Factors | |
dc.subject | Carcinoma, Basal Cell | |
dc.subject | Carcinoma, Squamous Cell | |
dc.subject | Cicatrix | |
dc.subject | Head and Neck Neoplasms | |
dc.subject | Humans | |
dc.subject | Neoplasm Invasiveness | |
dc.subject | Risk Factors | |
dc.subject | Skin Neoplasms | |
dc.subject | afamelanotide | |
dc.subject | alpha2a interferon | |
dc.subject | alpha2b interferon | |
dc.subject | aminolevulinic acid | |
dc.subject | betulic acid | |
dc.subject | betulin | |
dc.subject | capecitabine | |
dc.subject | celecoxib | |
dc.subject | cetuximab | |
dc.subject | cyclooxygenase 2 inhibitor | |
dc.subject | cyclopamine | |
dc.subject | epidermal growth factor receptor kinase inhibitor | |
dc.subject | erlotinib | |
dc.subject | fluorouracil | |
dc.subject | gefitinib | |
dc.subject | imiquimod | |
dc.subject | interferon | |
dc.subject | isotretinoin | |
dc.subject | lupeol | |
dc.subject | oleanolic acid | |
dc.subject | panitumumab | |
dc.subject | photofrin | |
dc.subject | protoporphyrin | |
dc.subject | resiquimod | |
dc.subject | retinoic acid | |
dc.subject | retinoid | |
dc.subject | tazarotene | |
dc.subject | unindexed drug | |
dc.subject | verteporfin | |
dc.subject | vismodegib | |
dc.subject | actinic keratosis | |
dc.subject | basal cell carcinoma | |
dc.subject | cancer mortality | |
dc.subject | cancer radiotherapy | |
dc.subject | carbon dioxide laser | |
dc.subject | conservative treatment | |
dc.subject | cryotherapy | |
dc.subject | curettage | |
dc.subject | desiccation | |
dc.subject | disease severity | |
dc.subject | electrodesiccation | |
dc.subject | external beam radiotherapy | |
dc.subject | head and neck cancer | |
dc.subject | head and neck squamous cell carcinoma | |
dc.subject | human | |
dc.subject | laser | |
dc.subject | morbidity | |
dc.subject | neodymium laser | |
dc.subject | neodymium YAG laser | |
dc.subject | nonhuman | |
dc.subject | nonmelanoma skin cancer | |
dc.subject | photodynamic therapy | |
dc.subject | review | |
dc.subject | risk factor | |
dc.subject | skin cancer | |
dc.subject | skin tumor | |
dc.subject | squamous cell carcinoma | |
dc.subject | treatment response | |
dc.title | Nonmelanoma Skin Cancer of the Head and Neck: Nonsurgical Treatment | |
dc.type | Review |